Crucell NV (CRXL) Ticks Higher On Sanofi-Aventis (SNY) Takeover Speculation
Tweet Send to a Friend
Crucell NV (Nasdaq: CRXL) is modestly higher today (+1%) following reports in the Wall Street Journal that french drug giant ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


